Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Certara Inc
(NQ:
CERT
)
10.36
+0.59 (+6.04%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Certara Inc
< Previous
1
2
3
Next >
Forecasting The Future: 4 Analyst Projections For Certara
November 07, 2024
Via
Benzinga
Beyond The Numbers: 4 Analysts Discuss Certara Stock
October 15, 2024
Via
Benzinga
Beyond The Numbers: 4 Analysts Discuss Certara Stock
September 27, 2024
Via
Benzinga
IonQ, Biomea Fusion, Rocket Lab USA And Other Big Stocks Moving Higher On Friday
September 27, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 27, 2024
Via
Benzinga
CERT Stock Earnings: Certara Misses EPS, Misses Revenue for Q2 2024
August 06, 2024
CERT stock results show that Certara missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Decoding 4 Analyst Evaluations For Certara
April 04, 2024
Via
Benzinga
Analyst Scoreboard: 4 Ratings For Certara
March 01, 2024
Via
Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
CERT Stock Earnings: Certara Meets EPS, Beats Revenue for Q1 2024
May 07, 2024
CERT stock results show that Certara met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Tax Season Is Here: Meet The New Federal Program That Can Eat Away At Tax Preparation Companies
January 30, 2024
New IRS program launching for free tax filing could affect tax prep companies like H&R Block and Intuit. Market share drop could impact ETFs.
Via
Benzinga
Recap: Certara Q3 Earnings
November 08, 2023
Via
Benzinga
The Latest Analyst Ratings for Certara
October 11, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023
August 22, 2023
Via
Benzinga
The Latest Analyst Ratings for Certara
August 11, 2023
Via
Benzinga
Looking Into Certara's Return On Capital Employed
May 22, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023
August 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 10, 2023
Via
Benzinga
Analyst Expectations for Certara's Future
April 12, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023
April 03, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
April 12, 2023
Via
Benzinga
Expert Ratings for Certara
March 27, 2023
Via
Benzinga
Signet Jewelers, Designer Brands, Academy Sports and Outdoors And Other Big Stocks Moving Higher On Thursday
March 16, 2023
U.S. stocks traded lower, with the Dow Jones dropping more than 250 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Where Certara Stands With Analysts
March 02, 2023
Via
Benzinga
Earnings Scheduled For March 1, 2023
March 01, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
April 04, 2023
Via
Benzinga
Macy's, Big Lots, Sprouts Farmers Market And Other Big Stocks Moving Higher On Thursday
March 02, 2023
U.S. stocks traded mixed, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 16, 2023
Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy...
Via
Benzinga
Why Certara's Shares Rose 37.7% This Week
November 11, 2022
The company, which helps other companies in their drug development, reported strong third-quarter numbers.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.